Elixinol Wellness Limited
ELLXF
$0.012
$0.000.00%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 80.06% | 69.50% | 54.85% | 33.04% | 12.08% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 80.06% | 69.50% | 54.85% | 33.04% | 12.08% |
| Cost of Revenue | 91.25% | 83.52% | 71.39% | 44.23% | 17.64% |
| Gross Profit | 62.97% | 49.02% | 31.88% | 17.67% | 4.52% |
| SG&A Expenses | -5.43% | -10.29% | -15.97% | -23.88% | -29.62% |
| Depreciation & Amortization | 73.58% | 66.50% | 56.22% | 10.82% | -21.62% |
| Other Operating Expenses | 198.87% | 141.48% | 84.65% | 42.69% | -2.87% |
| Total Operating Expenses | 38.93% | 27.89% | 15.04% | -3.81% | -18.89% |
| Operating Income | 17.13% | 21.11% | 25.57% | 34.88% | 41.08% |
| Income Before Tax | 29.64% | 15.96% | 2.24% | 21.46% | 33.06% |
| Income Tax Expenses | -118,690.00% | -70,794.12% | -14.29% | 14.29% | 42.86% |
| Earnings from Continuing Operations | 77.29% | 41.17% | 2.24% | 21.45% | 33.04% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 77.29% | 41.17% | 2.24% | 21.45% | 33.04% |
| EBIT | 17.13% | 21.11% | 25.57% | 34.88% | 41.08% |
| EBITDA | 21.45% | 23.30% | 25.95% | 34.85% | 40.80% |
| EPS Basic | 87.54% | 68.44% | 53.29% | 53.60% | 53.53% |
| Normalized Basic EPS | 67.71% | 65.67% | 64.91% | 61.34% | 58.81% |
| EPS Diluted | 87.34% | 68.16% | 52.93% | 53.43% | 53.47% |
| Normalized Diluted EPS | 67.71% | 65.67% | 64.91% | 61.34% | 58.81% |
| Average Basic Shares Outstanding | 160.95% | 149.93% | 134.49% | 93.62% | 49.90% |
| Average Diluted Shares Outstanding | 160.95% | 149.93% | 134.49% | 93.62% | 49.90% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |